99 related articles for article (PubMed ID: 27125842)
1. Glioma progression is mediated by an addiction to aberrant IGFBP2 expression and can be blocked using anti-IGFBP2 strategies.
Phillips LM; Zhou X; Cogdell DE; Chua CY; Huisinga A; R Hess K; Fuller GN; Zhang W
J Pathol; 2016 Jul; 239(3):355-64. PubMed ID: 27125842
[TBL] [Abstract][Full Text] [Related]
2. METTL3-mediated HOTAIRM1 promotes vasculogenic mimicry icontributionsn glioma via regulating IGFBP2 expression.
Wu Z; Wei N
J Transl Med; 2023 Nov; 21(1):855. PubMed ID: 38012763
[TBL] [Abstract][Full Text] [Related]
3. IGFBP2 from a novel copper metabolism-associated biomarker promoted glioma progression and response to immunotherapy.
Luo Q; Zhuang J; Zheng D; Miao C; Luo H; Peng J; Zheng C; Qin C; Lan C; Chen M; Xia Y; Huang D; Chen Z
Front Immunol; 2023; 14():1282734. PubMed ID: 37928523
[TBL] [Abstract][Full Text] [Related]
4. Protein structuromics: A new method for protein structure-function crosstalk in glioma.
Xiao N; Yang W; Wang J; Li J; Zhao R; Li M; Li C; Liu K; Li Y; Yin C; Chen Z; Li X; Jiang Y
Proteins; 2024 Jan; 92(1):24-36. PubMed ID: 37497743
[TBL] [Abstract][Full Text] [Related]
5. IGFBP2 levels associated with Alzheimer disease.
Kiani L
Nat Rev Neurol; 2024 Jan; 20(1):1. PubMed ID: 38049639
[No Abstract] [Full Text] [Related]
6. IGFBP2: integrative hub of developmental and oncogenic signaling network.
Li T; Forbes ME; Fuller GN; Li J; Yang X; Zhang W
Oncogene; 2020 Mar; 39(11):2243-2257. PubMed ID: 31925333
[TBL] [Abstract][Full Text] [Related]
7. IGFBP2 promotes neural stem cell maintenance and proliferation differentially associated with glioblastoma subtypes.
Shen F; Song C; Liu Y; Zhang J; Wei Song S
Brain Res; 2019 Feb; 1704():174-186. PubMed ID: 30347220
[TBL] [Abstract][Full Text] [Related]
8. Identification of Hypoxia Prognostic Signature in Glioblastoma Multiforme Based on Bulk and Single-Cell RNA-Seq.
Ahmed YB; Ababneh OE; Al-Khalili AA; Serhan A; Hatamleh Z; Ghammaz O; Alkhaldi M; Alomari S
Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339384
[TBL] [Abstract][Full Text] [Related]
9. IGFBP2 promotes proliferation and cell migration through STAT3 signaling in Sonic hedgehog medulloblastoma.
Kunhiraman H; McSwain L; Shahab SW; Gershon TR; MacDonald TJ; Kenney AM
Acta Neuropathol Commun; 2023 Apr; 11(1):62. PubMed ID: 37029430
[TBL] [Abstract][Full Text] [Related]
10. MALDI Imaging Mass Spectrometry of High-Grade Gliomas: A Review of Recent Progress and Future Perspective.
Rončević A; Koruga N; Soldo Koruga A; Debeljak Ž; Rončević R; Turk T; Kretić D; Rotim T; Krivdić Dupan Z; Troha D; Perić M; Šimundić T
Curr Issues Mol Biol; 2023 Jan; 45(2):838-851. PubMed ID: 36826000
[TBL] [Abstract][Full Text] [Related]
11. Secreted PGK1 and IGFBP2 contribute to the bystander effect of miR-10b gene editing in glioma.
Zhang Y; Rabinovsky R; Wei Z; El Fatimy R; Deforzh E; Luan B; Peshkin L; Uhlmann EJ; Krichevsky AM
Mol Ther Nucleic Acids; 2023 Mar; 31():265-275. PubMed ID: 36700043
[TBL] [Abstract][Full Text] [Related]
12. circSMARCA5 Is an Upstream Regulator of the Expression of miR-126-3p, miR-515-5p, and Their mRNA Targets,
Merulla AE; Stella M; Barbagallo C; Battaglia R; Caponnetto A; Broggi G; Altieri R; Certo F; Caltabiano R; Ragusa M; Barbagallo GMV; Di Pietro C; Purrello M; Barbagallo D
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430152
[TBL] [Abstract][Full Text] [Related]
13. Spatial Transcriptomic Analysis of Ovarian Cancer Precursors Reveals Reactivation of IGFBP2 during Pathogenesis.
Wang Y; Huang P; Wang BG; Murdock T; Cope L; Hsu FC; Wang TL; Shih IM
Cancer Res; 2022 Dec; 82(24):4528-4541. PubMed ID: 36206311
[TBL] [Abstract][Full Text] [Related]
14. Anoikis resistance in diffuse glioma: The potential therapeutic targets in the future.
Zhu Z; Fang C; Xu H; Yuan L; Du Y; Ni Y; Xu Y; Shao A; Zhang A; Lou M
Front Oncol; 2022; 12():976557. PubMed ID: 36046036
[TBL] [Abstract][Full Text] [Related]
15. i-Modern: Integrated multi-omics network model identifies potential therapeutic targets in glioma by deep learning with interpretability.
Pan X; Burgman B; Wu E; Huang JH; Sahni N; Stephen Yi S
Comput Struct Biotechnol J; 2022; 20():3511-3521. PubMed ID: 35860408
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of Glioblastoma Multiforme-Literature Review.
Grochans S; Cybulska AM; Simińska D; Korbecki J; Kojder K; Chlubek D; Baranowska-Bosiacka I
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626018
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein 2A Expression in Cancer-Associated Fibroblasts and Cancer Cells Promotes Esophageal Squamous Cell Carcinoma Progression.
Shimizu M; Koma YI; Sakamoto H; Tsukamoto S; Kitamura Y; Urakami S; Tanigawa K; Kodama T; Higashino N; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572779
[TBL] [Abstract][Full Text] [Related]
18. IGFBP2 Is a Potential Master Regulator Driving the Dysregulated Gene Network Responsible for Short Survival in Glioblastoma Multiforme.
Kalya M; Kel A; Wlochowitz D; Wingender E; Beißbarth T
Front Genet; 2021; 12():670240. PubMed ID: 34211498
[TBL] [Abstract][Full Text] [Related]
19. Potential Role of Insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for Obesity-Related Insulin Resistance.
Boughanem H; Yubero-Serrano EM; López-Miranda J; Tinahones FJ; Macias-Gonzalez M
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498859
[TBL] [Abstract][Full Text] [Related]
20. Hub gene identification and prognostic model construction for isocitrate dehydrogenase mutation in glioma.
Jia Y; Yang W; Tang B; Feng Q; Dong Z
Transl Oncol; 2021 Jan; 14(1):100979. PubMed ID: 33290989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
